 |
|
|
| |
RNA LAUNCH SYSTEM ENABLES IN VITRO EVALUATION OF BEPIROVIRSEN EFFICACY AGAINST HBV VARIANTS
|
| |
| |
AASLD 2022 Nov 4-8
Yingpu Yu2*, Alexander Koenig1*, Christine Livingston1, Hardeep van
Gijzel4, Rob Elston3, Dickens Theodore3, Melanie T. Paff3, Charles M. Rice2,
Shihyun You1, William M. Schneider2*
1GSK, Upper Providence, PA, USA, Infectious Diseases Research Unit; 2The Rockefeller University, NY, USA, Laboratory of Virology and Infectious Disease; 3GSK, Upper Providence, PA, USA, Clinical Development; 4 GSK, Upper Providence, PA, USA, Human Genetics Computational Biology; *Contributes equally, Presenter
|
| |
|
|
|
|
|
